Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Skin & Soft Tissues Diseases specialty page provides skin & soft tissue-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

SKIN & SOFT TISSUE DISEASES NEWS - Page 1

Impact of MRSA on Lymphatic Function Studied by MGH Investigators
Investigators from Massachusetts General Hospital (MGH) have made some interesting findings about methicillin-resistant Staphylococcus aureu (MRSA) that may hold the key to curbing lymphatic repercussions. 
 
Sepsis Survivors Need Better Rehabilitation Care After Hospital Discharge
Rates of re-hospitalization and long-term health effects remain high among sepsis survivors, which is why researchers are outlining ways to help sepsis patients after hospital discharge.
<em>Gardnerella</em> Bacteremia Reported in HIV-Positive Male
Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.
Achaogen's NDA for Plazomicin Accepted for Priority Review
Plazomicin is a next-generation aminoglycoside with in vitro activity against multidrug-resistant Enterobacteriaceae.
Will 2018 See the End of Polio? Public Health Watch Report
Could 2018 finally be the year polio is eliminated as a global health concern?
 
Vaccine Effective Against 91% of Bacteria Causing Common Invasive Meningococcal Disease in US
Researchers have found that the 4-component vaccine MenB-4C (Bexsero) is effective against up to 91% of strains of the bacteria Neisseria meningitidis, which causes meningococcal disease.
 
Can Tooth Decay Explain the Pathogenesis of Certain Infectious Diseases?
A review in Trends in Microbiology provides insight into the role of biofilms in the pathogenesis of polymicrobial infectious diseases.
Shingles Vaccine Approved by FDA
The FDA has approved Shingrix, GlaxoSmithKline’s recombinant zoster vaccine against shingles, for patients 50 and older.
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x